Treatment of refractory acute rejection in a lung transplant recipient with campath 1H

Transplantation. 2002 Sep 27;74(6):903-4. doi: 10.1097/00007890-200209270-00034.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Disease
  • Adult
  • Alemtuzumab
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / therapeutic use*
  • Antigens, CD
  • Antigens, Neoplasm*
  • CD52 Antigen
  • Glycoproteins / antagonists & inhibitors*
  • Graft Rejection / therapy*
  • Humans
  • Lung Transplantation / adverse effects*
  • Male

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antigens, CD
  • Antigens, Neoplasm
  • CD52 Antigen
  • CD52 protein, human
  • Glycoproteins
  • Alemtuzumab